Renovorx Inc (RNXT)

Jun 16, 2025

Short Interest in RenovoRx, Inc. (NASDAQ:RNXT) Declines By 35.4% - Defense World

Jun 16, 2025

Jun 12, 2025

Citadel Advisors LLC Invests $49,000 in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World

Jun 12, 2025

Jun 10, 2025

RenovoRX chief medical officer buys $29,399 in common stock By Investing.com - Investing.com Canada

Jun 10, 2025

Jun 09, 2025

RenovoRX chief medical officer buys $29,399 in common stock - Investing.com Australia

Jun 09, 2025

Jun 09, 2025

Insider Buying: Ramtin Agah Acquires Additional Shares of RenovoRx Inc (RNXT) - GuruFocus

Jun 09, 2025

Jun 08, 2025

RenovoRx (NASDAQ:RNXT) Stock Rating Upgraded by Wall Street Zen - Defense World

Jun 08, 2025

Jun 06, 2025

RenovoRx (NASDAQ:RNXT) Given New $11.50 Price Target at Ascendiant Capital Markets - Defense World

Jun 06, 2025

Jun 06, 2025

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results - Yahoo Finance

Jun 06, 2025

Jun 05, 2025

Ascendiant Capital raises RenovoRx stock price target to $11.50 By Investing.com - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

RenovoRx (RNXT) Price Target Increased by Ascendiant Analyst | R - GuruFocus

Jun 05, 2025

Jun 05, 2025

RenovoRx (RNXT) Price Target Increased by Ascendiant Analyst | RNXT Stock News - GuruFocus

Jun 05, 2025

Jun 05, 2025

RenovoRx (RNXT) Price Target Raised to $11.50 by Ascendiant Capi - GuruFocus

Jun 05, 2025

Jun 05, 2025

Ascendiant Capital raises RenovoRx stock price target to $11.50 - Investing.com

Jun 05, 2025

May 29, 2025

New U.S. Patent Issued to RenovoRx for Drug Therapy Platform - Medical Product Outsourcing

May 29, 2025

May 26, 2025

RenovoRx (NASDAQ:RNXT) Is Revolutionizing Cancer Treatment - simplywall.st

May 26, 2025

May 22, 2025

Q2 Earnings Forecast for RenovoRx Issued By HC Wainwright - Defense World

May 22, 2025

May 21, 2025

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 21, 2025

May 20, 2025

RenovoRx (NASDAQ:RNXT) Receives “Buy” Rating from HC Wainwright - Defense World

May 20, 2025

May 20, 2025

RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook - TipRanks

May 20, 2025

May 19, 2025

RenovoRx (RNXT): HC Wainwright Reiterates Buy Rating with $3.00 Target | RNXT Stock News - GuruFocus

May 19, 2025

May 18, 2025

RenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025

May 17, 2025

RenovoRx’s Innovative Drug Delivery and Promising Clinical Trials Earn a Buy Rating - TipRanks

May 17, 2025

May 16, 2025

RenovoRx Earnings Call: Positive Outlook Amid Growth - TipRanks

May 16, 2025

May 16, 2025

RenovoRx Inc (RNXT) Q1 2025 Earnings: EPS of -$0.08 Beats Estima - GuruFocus

May 16, 2025

May 16, 2025

RenovoRx earnings beat, revenue fell short of estimates - Investing.com Australia

May 16, 2025

May 16, 2025

Earnings call transcript: RenovoRx Q1 2025 revenue exceeds expectations By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

RenovoRx Reports Promising Q1 2025 Financial Results - TipRanks

May 16, 2025

May 15, 2025

Earnings call transcript: RenovoRx Q1 2025 revenue exceeds expectations - Investing.com

May 15, 2025

May 15, 2025

RenovoRx earnings beat, revenue fell short of estimates By Investing.com - Investing.com India

May 15, 2025

May 15, 2025

RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace

May 15, 2025

May 15, 2025

RenovoRx Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025

May 15, 2025

RenovoRx reports Q1 EPS (8c), consensus (8c) - TipRanks

May 15, 2025

May 15, 2025

RenovoRx (RNXT) Reports Strong Q1 Revenue Surpassing Expectations | RNXT Stock News - GuruFocus

May 15, 2025

May 15, 2025

RenovoRx Reports Strong Q1 2025 Financial Results - TipRanks

May 15, 2025

May 14, 2025

RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st - BioSpace

May 14, 2025

May 08, 2025

RenovoRx Expands RenovoCath Production to Meet an Increasing Demand - Zenopa

May 08, 2025

May 08, 2025

Renaissance Technologies LLC Makes New Investment in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World

May 08, 2025

May 06, 2025

RenovoRx Ramps Up U.S. Production of RenovoCath Devices - Medical Product Outsourcing

May 06, 2025

May 06, 2025

U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform - Business Wire

May 06, 2025

May 02, 2025

RenovoRx (RNXT) Projected to Post Earnings on Friday - Defense World

May 02, 2025

May 01, 2025

RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET - BioSpace

May 01, 2025

Apr 30, 2025

CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer - Curetoday

Apr 30, 2025

Apr 30, 2025

Ascendiant Capital Markets Forecasts Strong Price Appreciation for RenovoRx (NASDAQ:RNXT) Stock - The AM Reporter

Apr 30, 2025

Apr 29, 2025

RenovoRx (RNXT) Advances Phase III Trial for Pancreatic Cancer T - GuruFocus

Apr 29, 2025

Apr 29, 2025

RenovoRx (RNXT) Advances Phase III Trial for Pancreatic Cancer Treatment | RNXT Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

Johns Hopkins Medicine Initiates Patient Enrollment For Renovorx'S Ongoing Phase III Tiger-Pac Clinical Trial - marketscreener.com

Apr 29, 2025